Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Nuclear Factor I-X May Regulate a Myeloid-Biased Hematopoietic Stem Cell Population during Stress Hematopoiesis

Megan Walker, MS, Trent Hall, BS, MS, Scott A Brown, PhD, Shannon McKinney-Freeman, PhD

Blood (2018) 132 (Supplement 1): 5084.

https://doi.org/10.1182/blood-2018-99-118378

Published: 2018

Journal Articles

Positive Stool Cultures Could Predict the Clinical Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation

Lijuan Hu, Qi Wang, PhD, Xiaohui Zhang, Lan-Ping Xu, MD, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Kaiyan Liu, MD PhD, Hui Wang, PhD, Xiaojun Huang, MD, Xiao-Dong Mo

Blood (2018) 132 (Supplement 1): 5757.

https://doi.org/10.1182/blood-2018-99-109858

Published: 2018

Journal Articles

Targeted Inhibition of STAT/TET1 Axis As a Potent Therapeutic Strategy for Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 857.

https://doi.org/10.1182/blood.V130.Suppl_1.857.857

Published: 2017

Journal Articles

Regulation of Asymmetric Division in Myeloid Leukemogenesis

Jeevisha Bajaj, PhD, Eric L Van Nostrand, PhD, Gene W Yeo, PhD, Tannishtha Reya, PhD

Blood (2017) 130 (Supplement 1): 46.

https://doi.org/10.1182/blood.V130.Suppl_1.46.46

Published: 2017

Journal Articles

DLX1 Affects Cell Cycle and Proliferation of Myeloid Leukemia Cells In Vitro and In Vivo

Katerina Rejlova, Miroslava Kardosova, Martina Slamova, Marketa Zaliova, Meritxell Alberich-Jorda, Jan Trka, MD PhD, Julia Starkova

Blood (2016) 128 (22): 1666.

https://doi.org/10.1182/blood.V128.22.1666.1666

Published: 2016

Journal Articles

Thrombopoietin Has Neural Protective Effect in a Neonatal Rat Model of Hypoxic-Ischemic Brain Damage

Mo Yang, PhD, Lei Liu, MB, Enyu Liang, MB, Beng H Chong, PhD, Chunfu Li, MD

Blood (2016) 128 (22): 5059.

https://doi.org/10.1182/blood.V128.22.5059.5059

Published: 2016

Journal Articles

Notch Signaling in Bone Marrow Nestin-Expressing Cells Controls Balance of Erythropoiesis at the Bone Marrow and Spleen

Tatsuhiro Sakamoto, MD, Naoshi Obara, MDPhD, Takayasu Kato, MD PhD, Luan Cao Sy, Hidekazu Nishikii, MD PhD, Mamiko Sakata-Yanagimoto, MD PhD, Satoru Takahashi, MDPhD, Shigeru Chiba, MD, PhD

Blood (2016) 128 (22): 432.

https://doi.org/10.1182/blood.V128.22.432.432

Published: 2016

Journal Articles

Neural Stem Cell Marker Nestin As a Novel Unfavorable Prognostic Biomarker for Multiple Myeloma

Hana Svachova, MD PhD, Lucie Rihova, MSc, PhD, Lenka Besse, PhD, Fedor Kryukov, MD PhD, Lenka Zahradova, MD PhD, Tomas Jelinek, MD, Katerina Gracova, MD, Jiri Jarkovsky, MSc, PhD, Roman Hájek

Blood (2016) 128 (22): 5608.

https://doi.org/10.1182/blood.V128.22.5608.5608

Published: 2016

Journal Articles

The Mir-193 Family Antagonizes Stem Cell Pathways and Is a Potent Tumor Suppressor in Childhood and Adult Acute Myeloid Leukemia

Blood (2015) 126 (23): 1244.

https://doi.org/10.1182/blood.V126.23.1244.1244

Published: 2015

Journal Articles

TPO plus Tanshinone IIA has neural protective effect and this effect may be mediated via its receptor c-mpl and PI3K/Akt signaling

Mo Yang, MD, PhD, Jie yu Ye, MD, PhD, Su yi Li, En yu Liang, Fan yi Meng, MD, Qizhou Lian, MD, PhD

Blood (2013) 122 (21): 5565.

https://doi.org/10.1182/blood.V122.21.5565.5565

Published: 2013

Journal Articles

A Proteomics-Based Approach To Identifying Mechanisms Of Cancer-Associated Thrombosis: Potential Role For Immunoglobulins

Alok A. Khorana, MD, Gregory C. Connolly, MD, Fred Hagen, PhD, Belinda Willard, PhD, Renuka Iyer, Keith R. McCrae, MD

Blood (2013) 122 (21): 1127.

https://doi.org/10.1182/blood.V122.21.1127.1127

Published: 2013

Journal Articles

The Oncogenic Transcription Factor STAT5 Triggers Aberrant Expression Of CD25 (IL-2RA) In Neoplastic Stem Cells In Ph + CML

Irina Sadovnik, M.Sc., Harald Herrmann, M.D., Sabine Cerny-Reiterer, D.V.M, Wolfgang Warsch, Ph.D., Andrea Hoelbl, Ph.D., Katharina Blatt, MSc, Ph.D., Barbara Peter, D.V.M., Gabriele Stefanzl, Msc, Gregor Hoermann, M.D., Ph.D., Susanne Herndlhofer, Berthold Streubel, M.D., Wolfgang R Sperr, M.D., Christine Mannhalter, Ph.D., Veronika Sexl, MD, Peter Valent

Blood (2013) 122 (21): 3979.

https://doi.org/10.1182/blood.V122.21.3979.3979

Published: 2013

Journal Articles

Identification of a Novel Inhibitor That Selectively Targets NF-κB Activity in KSHV-Infected Lymphoma Cells

Utthara Nayar, PhD, Gunkut Akar, Robert H Shoemaker, PhD, Shizuko Sei, MD, Ethel Cesarman, MD, PhD

Blood (2012) 120 (21): 160.

https://doi.org/10.1182/blood.V120.21.160.160

Published: 2012

Journal Articles

Histone Alterations Are Associated with Hematopoietic Stem Cell (HSC) Differentiation and Aging

Min Luo, Ph.D., Mira Jeong, Ph.D., Deqiang Sun, Ph.D., Hui Wang, Ph.D., Rui Chen, Ph.D., Wei Li, Ph.D., Gretchen Darlington, Ph.D., Margaret A. Goodell, PhD

Blood (2012) 120 (21): 1188.

https://doi.org/10.1182/blood.V120.21.1188.1188

Published: 2012

Journal Articles

A Phase II Trial of Azacitidine (NSC-102816) and Gemtuzumab Ozogamicin (NSC-720568) As Induction and Post-Remission Therapy in Patients of Age 60 and Older with Previously Untreated Non-M3 Acute Myeloid Leukemia (SWOG S0703): Report On the Poor Risk Patients

Sucha Nand, MD, Megan Othus, PhD, John E. Godwin, MD, MS, Cheryl L Willman, MD, Thomas Norwood, Harry Paul Erba, MD, PhD, Dianna Howard, MD, Steven E. Coutre, MD, Frederick R. Appelbaum, MD

Blood (2012) 120 (21): 3584.

https://doi.org/10.1182/blood.V120.21.3584.3584

Published: 2012

Journal Articles

Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory Indolent B-Cell Neoplasms - Update of the “Bolus” Infusion Schedule of Alvocidib.

Beata Holkova, MD, Edward B. Perkins, MD, PhD, Prithviraj Bose, MD, Daniel M Sullivan, MD, Rachid Baz, MD, Mary Beth Tombes, RN, Ellen Shrader, Viswanathan Ramakrishnan, PhD, Wen Wan, PhD, Heidi Sankala, PhD, Maciej Kmieciak, PhD, John D. Roberts, MD, Steven Grant, MD

Blood (2012) 120 (21): 2959.

https://doi.org/10.1182/blood.V120.21.2959.2959

Published: 2012

Journal Articles

TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia

Ilaria Iacobucci, PhD, Anna Ferrari, Stefania Trino, Annalisa Lonetti, Cristina Papayannidis, Alberto Ferrarini, Luca Venturini, Maria Chiara Abbenante, Sarah Parisi, Federica Cattina, MD, Simona Soverini, Stefania Paolini, Domenico Russo, Marco Vignetti, Fabrizio Pane, Pellegrino Musto, Massimo Delledonne, Michele Baccarani, MD, Giovanni Martinelli, MD

Blood (2011) 118 (21): 1484.

https://doi.org/10.1182/blood.V118.21.1484.1484

Published: 2011

Journal Articles

Oxygen Availability and Stem Cells: Impact On Development and Disease

M. Celeste Simon, PhD

Blood (2011) 118 (21): SCI-37.

https://doi.org/10.1182/blood.V118.21.SCI-37.SCI-37

Published: 2011

Journal Articles

Cord Blood-derived neurons by ectopic expression of SOX2 and c-MYC

Alessandra Giorgetti, Leopoldo Laricchia-Robbio, Raffaella Fazzina, Maria-Carolina Marchetto, Diana Yu, Mo Li, Yangling Mu, Antonio Adamo, Ida Paramonov, Julio Castaño-Cardoso, Montserrat Barragan, Fred Gage, Juan Carlos Izpisua

Blood (2011) 118 (21): 2350.

https://doi.org/10.1182/blood.V118.21.2350.2350

Published: 2011

Journal Articles

Bone Marrow-Derived Mesenchymal Stem Cell Homing to Breast Cancer but Not Colon and Renal Cancer and VEGF-C and VEGF-R3 Play the Key Role in Tumor Homing Effect in the Syngeneic Mice (Balb/c) Model,

Su-Peng Yeh, Wen-Jyi Lo, Chang-Fang Chiu

Blood (2011) 118 (21): 3418.

https://doi.org/10.1182/blood.V118.21.3418.3418

Published: 2011

NARROW

Nuclear Factor I-X May Regulate a Myeloid-Biased Hematopoietic Stem Cell Population during Stress Hematopoiesis

Positive Stool Cultures Could Predict the Clinical Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation

Targeted Inhibition of STAT/TET1 Axis As a Potent Therapeutic Strategy for Acute Myeloid Leukemia

Regulation of Asymmetric Division in Myeloid Leukemogenesis

DLX1 Affects Cell Cycle and Proliferation of Myeloid Leukemia Cells In Vitro and In Vivo

Thrombopoietin Has Neural Protective Effect in a Neonatal Rat Model of Hypoxic-Ischemic Brain Damage

Notch Signaling in Bone Marrow Nestin-Expressing Cells Controls Balance of Erythropoiesis at the Bone Marrow and Spleen

Neural Stem Cell Marker Nestin As a Novel Unfavorable Prognostic Biomarker for Multiple Myeloma

The Mir-193 Family Antagonizes Stem Cell Pathways and Is a Potent Tumor Suppressor in Childhood and Adult Acute Myeloid Leukemia

TPO plus Tanshinone IIA has neural protective effect and this effect may be mediated via its receptor c-mpl and PI3K/Akt signaling

A Proteomics-Based Approach To Identifying Mechanisms Of Cancer-Associated Thrombosis: Potential Role For Immunoglobulins

The Oncogenic Transcription Factor STAT5 Triggers Aberrant Expression Of CD25 (IL-2RA) In Neoplastic Stem Cells In Ph + CML

Identification of a Novel Inhibitor That Selectively Targets NF-κB Activity in KSHV-Infected Lymphoma Cells

Histone Alterations Are Associated with Hematopoietic Stem Cell (HSC) Differentiation and Aging

A Phase II Trial of Azacitidine (NSC-102816) and Gemtuzumab Ozogamicin (NSC-720568) As Induction and Post-Remission Therapy in Patients of Age 60 and Older with Previously Untreated Non-M3 Acute Myeloid Leukemia (SWOG S0703): Report On the Poor Risk Patients

Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory Indolent B-Cell Neoplasms - Update of the “Bolus” Infusion Schedule of Alvocidib.

TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia

Oxygen Availability and Stem Cells: Impact On Development and Disease

Cord Blood-derived neurons by ectopic expression of SOX2 and c-MYC

Bone Marrow-Derived Mesenchymal Stem Cell Homing to Breast Cancer but Not Colon and Renal Cancer and VEGF-C and VEGF-R3 Play the Key Role in Tumor Homing Effect in the Syngeneic Mice (Balb/c) Model,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only